Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 531 of 5804
-
New drug duo aims to tackle tough leukemia
Disease control Recruiting nowThis Phase I/II trial evaluates the safety and preliminary efficacy of DFP-10917 combined with venetoclax in relapsed or refractory acute myeloid leukemia. DFP-10917 is given as a 14-day continuous IV infusion every 28 days, alongside a 14-day oral course of venetoclax following …
Phase: PHASE1, PHASE2 • Sponsor: Delta-Fly Pharma, Inc. • Aim: Disease control
Last updated Jun 26, 2026 12:50 UTC
-
Brain tumor patients get infused with a genetically altered herpes virus
Disease control Recruiting nowThis is a Phase 1 open label study designed to assess the safety and tolerability of the oncolytic herpes simplex virus 1 (oHSV1) study drug, MVR-C5252, administered intratumorally by convection-enhanced delivery (CED) in patients with recurrent high-grade glioma. Once the safety…
Phase: PHASE1 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New implant could help amputees walk better and avoid infections
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and effectiveness of the Transdermal Compress device in participants with Transfemoral Amputations.
Phase: NA • Sponsor: Balmoral Medical company • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug duo aims to tackle tough lymphoma
Disease control Recruiting nowThis phase II trial tests the safety and effectiveness of glofitamab given in combination with pirtobrutinib in treating patients with mantle cell lymphoma that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory). Gl…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Gene therapy injection aims to halt blinding eye disease
Disease control Recruiting nowThis study is an open-label, single ascending dose clinical trial in participants who have ABCA4-related retinopathies. This is the first-in-human clinical trial in which ACDN-01 will be evaluated for safety, tolerability, and preliminary efficacy following a single subretinal in…
Phase: PHASE1, PHASE2 • Sponsor: Ascidian Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New combo tackles Drug-Resistant lung cancer in early trial
Disease control Recruiting nowAs the 3rd generation, EGFR TKI has become a standard treatment option for the 1st line therapy in EGFR mutated patients, the necessity for evaluating resistant mechanism to determine the matched subsequent therapeutic option has been highlighted. From the 1st line Osimertinib tr…
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Brain zaps tailored to you: new PTSD therapy shows promise
Symptom relief Recruiting nowA battery of physiological and behavioral data will be collected before and after application of eTMS. Participants will be veterans or first responders diagnosed with PTSD. Study will be a double-blind, sham-controlled, parallel group, randomized clinical trial.
Phase: NA • Sponsor: Virginia Polytechnic Institute and State University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
AI reads eye photos to spot Diabetes-Related vision loss
Diagnosis TerminatedThis prospective study aims to validate if NeoRetina, an artificial intelligence algorithm developped by DIAGNOS Inc. and trained to automatically detect the presence of diabetic retinopathy (DR) by the analysis of macula centered eye fundus photographies, can detect this disease…
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
New vaccine could help throat cancer patients avoid radiation
Disease control Recruiting nowBackground: Throat cancer is a common tumor that can occur in people infected with the human papilloma virus (HPV). Most people with this cancer survive more than 5 years with standard chemotherapy drugs plus radiation. But radiation can cause serious adverse effects. Researcher…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Spinal zaps may help paralyzed patients exercise harder
Disease control Recruiting nowOur overall objective is to decrease the prevalence of multiple sedentary-related diseases that are secondary consequences of spinal cord injury (SCI). SCI affects motor, sensory and autonomic systems and can cause very limited exercise capacity which then leads to very high rate…
Phase: NA • Sponsor: University of Manitoba • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Which talk therapy works best for binge eating? a Head-to-Head trial aims to find out
Disease control Recruiting nowThe HALO trial is designed as a four-armed, assessor-blinded, fidelity-monitored randomized clinical trial. The goal of this randomized controlled study is to investigate the effectiveness of four different psychotherapy programs and to determine which one is most effective in re…
Phase: NA • Sponsor: Herlev and Gentofte Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New shot could tame severe eczema in kids as young as 6 months
Disease control Recruiting nowThe purpose of this trial is to test whether treatment with tralokinumab (administered subcutaneous injections \[SC\]) in combination with topical corticosteroids (TCS) is safe and effective to treat moderate-to-severe atopic dermatitis (AD) in children and infants. This will be …
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New Non-Opioid pill shows promise in breaking opioid addiction cycle
Disease control CompletedThe purpose of this study is to measure safety and efficacy and to determine dose-response relationship for INDV-2000 in participants with moderate to severe Opioid Use Disorder (OUD) who are new to treatment, have recently initiated or completed short-term medically supervised w…
Phase: PHASE2 • Sponsor: Indivior Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New study aims to shield blood cancer patients from Post-CAR-T infections
Disease control Recruiting nowThis phase II trial compares the effects of immunoglobulin replacement therapy with a placebo for preventing infectious complications in patients receiving CD19 chimeric antigen receptor (CAR)-T cell therapy. Hypogammaglobulinemia is a common complication in patients who receive …
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
LSD trial aims to ease End-of-Life distress
Symptom relief Recruiting nowBackground: Terminally ill patients often experience significant psychosocial distress having depressed mood, death anxiety, pain, and an overall poor quality of life. Recent evidence from pilot studies suggests that serotonergic hallucinogens including lysergic acid diethylamide…
Phase: PHASE2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Gene-Editing heart therapy under 15-Year watch
Disease control ENROLLING_BY_INVITATIONLTF-001 is a long-term follow-up study of participants who received an investigational gene-editing therapy developed by the sponsor to evaluate the long-term effects of the investigational therapy. Participants will be followed for a total of 15 years after the first administrat…
Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Magic mushroom compound tested for PTSD relief in small study
Symptom relief OngoingThe proposed open-label, controlled study at the Johns Hopkins Center for Psychedelic and Consciousness Research (CPCR) will test the following primary hypotheses in adult patients with chronic PTSD who are currently taking a serotonin reuptake inhibitor: psilocybin therapy will …
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Hidden hearing aid? new implant could restore speech without visible parts
Disease control CompletedThe goal of this clinical trial is to test the Mi2000 Totally Implantable Cochlear Implant in a population of candidates for a cochlear implant. The main question it aims to answer is, whether the device is able to improve speech perception compared to the pre-operative score. P…
Phase: NA • Sponsor: MED-EL Elektromedizinische Geräte GesmbH • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Personalized dosing could improve lupus kidney treatment for kids
Disease control Recruiting nowThe study is a 1-year 2-part double-blinded placebo controlled 2-arm clinical trial. Treatment arms are (1) MMF dosed as per body-surface area (MMFBSA; 600mg/m2 body surface area per dose about every 12 hours) and (2) pharmacokinetically-guided precision-dosing of MMF (MMFPK; MMF…
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New combo therapy shows promise for tough esophageal cancer
Disease control Recruiting nowThis study was a single-center, single-arm, open-label phase II clinical trial. Thirty patients with unresectable locally advanced or postoperative recurrent esophageal squamous cell carcinoma were treated with concurrent chemoradiotherapy combined with immunotherapy. The radioth…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC